(ARDT) Ardent Health Partners - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03980N1072
ARDT: Hospitals, Clinics, Healthcare, Rehabilitation, Surgery
Ardent Health Partners, Inc. (NYSE: ARDT) is a prominent healthcare provider operating a diverse network of hospitals and clinics across the United States. Specializing in acute care, their facilities include rehabilitation and surgical hospitals, addressing a range of medical needs. Established in 2001 and headquartered in Brentwood, Tennessee, Ardent is a subsidiary of EGI-AM Investments, L.L.C., indicating a strategic private equity involvement that may influence their governance and growth strategies.
From a financial standpoint, Ardent boasts a market capitalization of approximately $2.59 billion, positioning it as a significant player in the healthcare sector. The current P/E ratio of 30.76 suggests investor confidence in its growth potential, while the forward P/E of 9.55 hints at anticipated valuation adjustments. The price-to-book ratio of 3.50 indicates a premium on their assets, possibly reflecting strong operational efficiency or brand value. Notably, the price-to-sales ratio of 0.46 underscores efficient revenue generation relative to their market value.
Operating in a competitive landscape, Ardent differentiates itself through a focus on operational excellence and patient-centric care. Their strategic approach to healthcare delivery emphasizes both clinical quality and cost efficiency, positioning them favorably in the market. This operational strategy, coupled with a strong financial profile, makes Ardent an attractive consideration for investors seeking exposure to the healthcare facilities sector.
Additional Sources for ARDT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ARDT Stock Overview
Market Cap in USD | 2,591m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2024-07-18 |
ARDT Stock Ratings
Growth Rating | -44.0 |
Fundamental | 58.1 |
Dividend Rating | 0.0 |
Rel. Strength | -16.4 |
Analysts | 4.4/5 |
Fair Price Momentum | 10.92 USD |
Fair Price DCF | 19.26 USD |
ARDT Dividends
No Dividends PaidARDT Growth Ratios
Growth Correlation 3m | -80.8% |
Growth Correlation 12m | -80.4% |
Growth Correlation 5y | -80.4% |
CAGR 5y | -22.10% |
CAGR/Max DD 5y | -0.53 |
Sharpe Ratio 12m | -0.20 |
Alpha | -26.84 |
Beta | 0.212 |
Volatility | 50.03% |
Current Volume | 427.4k |
Average Volume 20d | 435.9k |
As of April 19, 2025, the stock is trading at USD 12.51 with a total of 427,391 shares traded.
Over the past week, the price has changed by +3.30%, over one month by -11.15%, over three months by -11.28% and over the past year by -22.10%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.11 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of April 2025 is 10.92. This means that ARDT is currently overvalued and has a potential downside of -12.71%.
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
- Strong Buy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 11.8 in April 2026. The stock is currently trading at 12.51. This means that the stock has a potential downside of -5.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 22.8 | 82.1% |
Analysts Target Price | 22.8 | 82.1% |
ValueRay Target Price | 11.8 | -5.7% |